The eleventh issue of Regulatory Affairs Watch explores the opportunities and challenges of integrating artificial intelligence into clinical research while examining the evolving regulatory landscape. Through expert perspectives and practical examples, this issue highlights key ethical and legal considerations, the importance of patients and public involvement, regulatory aspects of medical device software, and emerging applications of AI in clinical trials.